Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

The goal of osteoporosis management is to prevent fractures. Several pharmacological
agents are available to lower fracture risk, either by reducing bone resorption or by …

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for
women in the United States and worldwide. There has been no American College of …

“The 2022 Hormone Therapy Position Statement of The North American Menopause
Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …

Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …

Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …

Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

Importance As many as 10% of women experience natural menopause by the age of 45
years. If confirmed, an increased risk of cardiovascular disease (CVD) and all-cause …

Background: Higher androgen and lower estrogen levels are associated with cardiovascular
disease (CVD) risk factors in women. However, studies on sex hormones and incident CVD …

Importance Health outcomes from the Women's Health Initiative Estrogen Plus Progestin
and Estrogen-Alone Trials have been reported, but previous publications have generally not …